Patents by Inventor Richard A. Hiles

Richard A. Hiles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of gestational diabetes
    Patent number: 7452858
    Abstract: Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: November 18, 2008
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Richard A. Hiles, Kathryn S. Prickett
  • Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
    Publication number: 20040266670
    Abstract: Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.
    Type: Application
    Filed: January 13, 2003
    Publication date: December 30, 2004
    Inventors: Richard A. Hiles, Kathryn S. Prickett
  • Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
    Publication number: 20040023871
    Abstract: Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.
    Type: Application
    Filed: June 5, 2003
    Publication date: February 5, 2004
    Inventors: Richard A. Hiles, Kathryn S. Prickett
  • Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
    Patent number: 6506724
    Abstract: Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: January 14, 2003
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Richard A. Hiles, Kathryn S. Prickett